Dr Emma Ball is Director Therapeutic Area Strategy and Business Development, CSL Limited and is located in Melbourne, Australia.  Her role involves searching for, evaluating and executing on business development opportunities as well as defining strategy for CSL’s therapeutic areas.  She trained initially as a molecular biologist and gained her PhD in 1999 from the University of Melbourne, followed by Postdoctoral studies in oncology and endocrinology at Monash University, Melbourne.  Emma also holds an MBA from RMIT University, Melbourne, and is a graduate of the Australian Institute of Company Directors (AICD).